Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-004743-23Phase 4Terminated
Phase 4, randomised, open-label trial of chlorhexidine and povidone-iodine in surgical site infection (SSI) (4 arms), sponsored by Hull University Teaching Hospitals. Primary endpoint: Occurrence of surgical site infection. Started Nov 2013; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-004743-23.